Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.

Clinical pharmacology and therapeutics - 1 Mar 2006

Lundblad Mia Sandberg, Ohlsson Staffan, Johansson Peter, Lafolie Pierre, Eliasson Erik

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Area Under Curve
Share to Aryl Hydrocarbon Hydroxylases
Share to Cyclooxygenase 2 Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Homozygote

Share to Pyrazoles

Share to Sulfonamides

Source

Identifiers

PMID: 16513453
DOI: 10.1016/j.clpt.2005.11.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.PMID 16513453Read ↗

Evaluation of the relationship between polymorphisms in CYP2C8 and CYP2C9 and the pharmacokinetics of celecoxib.Semantic proximity Read ↗

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?Semantic proximity Read ↗

Role of Genetic Variations in the Hepatic Handling of Drugs.Semantic proximity Read ↗

Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite.Semantic proximity Read ↗

Clinical consequences of cytochrome P450 2C9 polymorphisms.Semantic proximity Read ↗

CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.Semantic proximity Read ↗

Activation/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer TherapySemantic proximity Read ↗

CYP3A genetics in drug metabolismSemantic proximity Read ↗

Drugs as CYP3A Probes, Inducers, and InhibitorsSemantic proximity Read ↗

Reaction phenotyping to assess victim drug-drug interaction risks.Semantic proximity Read ↗

Celecoxib is a substrate of CYP2D6: Impact on celecoxib metabolism in individuals with CYP2C9*3 variants.Semantic proximity Read ↗

Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.